EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer

International Journal of Cancer

Volumn 106, Issue 3, 2003, Pages 310-315

  Takahashi, Satoru ^a   Urano, Tomohiko ^a   Tsuchiya, Fujiko ^b   Fujimura, Tetsuya ^a   Kitamura, Tadaichi ^a   Ouchi, Yasuyoshi ^a   Muramatsu, Masami ^b   Inoue, Satoshi ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

EBAG9; Estrogen responsive gene; Immune escape; Prognosis; RCASI

Indexed keywords

RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELLS; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BENIGN TUMOR; CANCER CELL; CANCER GROWTH; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; ESTROGEN RECEPTOR BINDING FRAGMENT ASSOCIATED GENE 9; ESTROGEN RESPONSIVE ELEMENT; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SURVIVAL RATE; WESTERN BLOTTING;

AGED; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; DISEASE PROGRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, ESTROGEN; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0037491753     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11205     Document Type: Article

References (29)

1. Watanabe T, Inoue S, Hiroi H, Orimo A, Kawashima H, Muramatsu M. Isolation of estrogen-responsive genes with a CpG island library. Mol Cell Biol 1998;18:442-9.
2. Tsuchiya F, Ikeda K, Tsutsumi O, Hiroi H, Momoeda M, Taketani Y, Muramatsu M, Inoue S. Molecular cloning and characterization of mouse EBAG9, homolog of a human cancer associated surface antigen: expression and regulation by estrogen. Biochem Biophys Res Commun 2001;284;2-10.
3. Sonoda K, Nakashima M, Saito T, Amada S, Kamura T, Nakano H, Watanabe T. Establishment of a new human uterine cervical adenocarcinoma cell line, SiSo, and its reactivity to anti-cancer reagents. Int J Oncol 1995;6:1099-104.
4. Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer (Phila) 1996;77:1501-9.
5. Sonoda K, Kaku T, Kamura T, Nakashima M, Watanabe T, Nakano H. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias. Clin Cancer Res 1998;4:1517-20.
6. Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nature Med 1999;5:938-42.
7. Villunger A, Strasser A. The great escape: is immune evasion required for tumor progression? Nature Med 1999;5:874-5.
8. Kaku T, Sonoda K, Kamura T, Hirakawa T, Sakai K. Ameda S, Ogawa S, Kobayashi H, Nakashima M, Watanabe T, Nakano H. Prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Clin Cancer Res 1999;5: 1449-53.
9. Iwasaki T, Nakashima M, Watanabe T, Yamamoto S, Inoue Y. Yamanaka H, Matsumura A, Iiuchi K. Mori T, Okada M. Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1. Int J Cancer 2000:89:488-93.
10. Noguchi K, Enjoji M, Nakamuta M, Nakashima M, Nishi H, Choi I, Taguchi K, Kotoh K, Shimada M, Sugimachi K, Tsuneyoshi M, Nawata H, Watanabe T. Expression a tumor-associated antigen RCAS1 in hepatocellular carcinoma. Cancer Lett 2001;168:197-202.
11. Izumi M, Nakanishi Y, Yoshino I, Nakashima M, Watanabe T, Hara N. Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma. Cancer 2001;92:446-51.
12. Kubokawa M, Nakashima M, Yao T, Ito KI, Harada N, Watanabe T. Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer. Int J Oncol 2001;19:695-700.
13. Takahashi H, Iizuka H, Nakashima M, Wada T, Asano K, Ishida-Yamamoto A, Watanabe T. RCAS1 antigen is highly expressed in extra mammary Paget's disease and in advanced stage squamous cell carcinoma of the skin. J Dermatol Sci 2001;26:140-4.
14. Suzuki T, Inoue S, Kawabata W, Akahira J, Moriya T, Tsuchiya F, Ogawa S, Muramatsu M, Sasano H. EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions. Br J Cancer 2001;85:1731-7.
15. Kuiper CG, Enmark E, Pelto-Huikko M, Nilson S, Gustafsson JA. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925-30.
16. Lau KM, LaSpina M, Long J. Ho SM. Expression of estrogen receptor (ER)-α and ER-β in normal and malignant prostate epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res 2000;60:3175-82.
17. Leav I, Lau KM, Adams JY, McNeal JE, Taplin M-E, Wang J, Singh H. Ho Shuk-Mei. Comparative studies of the estrogen receptors β and α and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol 2001; 159:79-92.
18. Pasquali D, Staibono S, Prezioso D. Franco R, Esposito D, Notaro A, De Rosa Gaetano, Bellastella A, Antonio N. Estrogen receptor β expression in human prostate tissue. Mol Cell Endocrinol 2001;178: 47-50.
19. Fujimura T, Takahashi S, Urano T, Ogawa S, Ouchi Y, Kitamura T, Muramatsu M, Inoue S. Differential expression of estrogen receptor β (ERβ) and its C-terminal truncated splice variant ERβcx as prognostic predictors in human prostatic cancer. Biochem Biophys Res Commun 2001;289:692-9.
20. Ogawa S, Inoue S, Watanabe T, Hiroi H, Orimo A, Hosoi T, Ouchi Y. Muramatsu M. Molecular cloning and characterization of human estrogen receptor beta-cx: A potential inhibitor of estrogen action in human. Nucleic Acids Res 1998;26:3505-12.
21. Hiroi H, Inoue S, Watanabe T, Goto W, Orimo A, Momoeda M, Tsutsumi O, Taketani Y, Muramastu M. Differential immunolocalization of estrogen receptor α and β in rat ovary and uterus. J Mol Endocrinol 1999;22:37-44.
22. Harvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker PD. et al. Frequent loss of estrogen receptor-β expression in prostate cancer. Cancer Res 2001;61:5331-5.
23. Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S, Sakai K, Nakashima M, Watanabe T, Nakano H. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium. Gynecol Oncol 2000;79: 424-9.
24. Matsushima T, Nakashima M, Oshima K, Abe Y, Nishimura J, Nawata H, Watanabe T, Muta K. Receptor binding cancer antigen expressed on SiSo cells, novel regulator of apoptosis of erythroid progenitor cells. Blood 2001;98:313-21.
25. Vesalainen S, Lipponen P, Talja M, Syrjanen K. Histological grade, perineural infiltration, tumor-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 1994;30A:1797-1803.
26. Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lakins J, Lupu R. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines. Oncol Rep 2000;7:157-67.
27. Ikeda K, Sato M, Tsutsumi O, Tsuchiya F, Tsuneizumi M, Emi M, Imoto I, Inazawa J, Muramatsu M, Inoue S. Promoter analysis and chromosomal mapping of human EBAG9 gene. Biochem. Biophys Res Commun 2000;273:654-60.
28. Royuela M, de Miguel MP, Bethencourt FR, Sanchez-Chapado M, Frile B, Arenas MI, Paniagua R. Estrogen receptor α and β in the normal, hyperplastic and carcinomous human prostate. J Endocrinol 2001;168:447-54.
29. Bonkhoff H, Fixemer T, Hunsicker I, Remberger K. Estrogen receptor expression in prostate cancer and premalignant prostatic lesions. Am J Pathol 1999;155:641-7.